News

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...
“Melanin mellow-yellow,” she captioned the series of striking poses, sending fans into a frenzy over her trim figure and ...
GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.
A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...
Uagnda's Dei BioPharma Ltd has announced that the U.S. Food and Drug Administration has accepted the development plan for two of its novel biological drugs, liraglutide and semaglutide, which are used ...
“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...
SIERRA Robichaud was among the first wave of people to see her excess fat melt away after starting weight loss jabs – and she ...
Certain batches of injectable medicines, including insulin and weight-loss drugs, were reported stolen in transit. Experts ...
Tennis Grand Slam champion Serena Williams has not only admitted that a GLP-1 medication helped her shed 31 pounds (14 kg) ...
Discover the risks and considerations of using weight loss injections originally for diabetics. Medical professionals ...